Why do people put "not investment advice" in their bios? Is there actually legal precedent, or do they just do copy others? Not investment advice.
Joined December 2023
- Tweets1.5K
- Following209
- Followers1.2K
- Likes3K
BaffledBiologist retweeted
$VSTM $IMRX $RVMD I hope everyone is enjoying the holidays! However, since I understand how much we biotech investors still need our daily data fix, here's a quick side-by-side comparison of Verastem, Imuneering, and Revolution.😆
Note, I am long one or more of these names (members can view more information at BiQ).
BaffledBiologist retweeted
If $REPL decides to stop further development of RP1 because it's financially unfeasible, I'll always be saddened by this KM curve and the patients who may have benefitted.
"empower patients to make choices right for them." -Prasad
BaffledBiologist retweeted
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book $BFRI tinyurl.com/2xjdmuah
BaffledBiologist retweeted
At times, we have a winner. Biotech is hard though $BFRI
BaffledBiologist retweeted
$BFRI Biofrontera gets FDA approval to increase the maximally approved dosage of Ameluz from one to three tubes for treatment of actinic keratoses. accessdata.fda.gov/drugsatfd…
BaffledBiologist retweeted
$SMMT - Summit Therapeutics. PD-1 and a VEGF (lol). 79% ownership by Robert Duggan (Pharmacyclics, Intuitive Surgical). No float. Up 100% YTD. All eggs in the basket that the FDA will accept Chinese data. H2H versus Pembro. Wild trial design. We could be in for an absolute ride.
